Mingyu Li
Neurology · Augusta, GANPI 1609541846
Payments from drug & device makers
Across 93 payments — averaging $31.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Livanova USA, Inc.$769
- Medtronic$136
- Neurelis, Inc.$124
- AbbVie$76
- Jazz Pharmaceuticals Inc.$68
- plus $607 from 20 others
What the payments were for
- Travel & lodging$2188%
- Food & beverage$2,67392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 45 | $1,111 |
| Livanova USA, Inc. | 7 | $769 |
| Medtronic | 3 | $136 |
| Neurelis, Inc. | 2 | $124 |
| AbbVie(2 entities) | 4 | $76 |
| Jazz Pharmaceuticals Inc. | 4 | $68 |
| SK Life Science, Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Ipsen Biopharmaceuticals, Inc | 3 | $53 |
| AstraZeneca(2 entities) | 3 | $46 |
| Lundbeck LLC | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| EMD Serono, Inc. | 1 | $29 |
| Amylyx Pharmaceuticals, Inc. | 1 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $27 |
| Argenx US, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Amgen | 1 | $25 |
| Averitas Pharma Inc. | 1 | $25 |
| Biogen | 1 | $24 |
| CSL Behring | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $16 |
| Greenwich Biosciences, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Chiesi USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,891 in reported general payments places this provider in the 55th percentile of 506 neurology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 11 | $7,550 |
| Gabapentin | 13 | $142 |
| Atorvastatin Calcium | 12 | $80 |
Paid to pharmacies, not to this prescriber.
Other neurology in Augusta
- John MorganAugusta$1.3M
- Alexis ShaeferAugusta$279K
- Askiel BrunoAugusta$275K
- Jerry PruittAugusta$121K
- Bryan HoAugusta$97K
- Debra Moore-HillAugusta$88K
- Kapil SethiAugusta$55K
- Jonathan LissColumbus$25M
- Marshall NashDecatur$13.6M
- James LahAtlanta$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.